New patent for Optinose Us drug XHANCE

Annual Drug Patent Expirations for XHANCE Xhance is a drug marketed by Optinose Us Inc and is included in one NDA. It is available from one supplier. There are thirteen…
The post New patent for Optinose Us drug XHANCE appeared first on DrugPatentWatch …


New patent for Novo Nordisk drug VICTOZA

Annual Drug Patent Expirations for VICTOZA Victoza is a drug marketed by Novo Nordisk Inc and is included in one NDA. It is available from one supplier. There are eight…
The post New patent for Novo Nordisk drug VICTOZA appeared first on DrugPatentWatc…


New patent expiration for Pfizer drug EXUBERA

Annual Drug Patent Expirations for EXUBERA Exubera is a drug marketed by Pfizer and is included in one NDA. There are three patents protecting this drug. This drug has three…
The post New patent expiration for Pfizer drug EXUBERA appeared first on Drug…


Will AI Help Challenge Drug Patents, or Strengthen Them?

Artificial intelligence is allowing chemists to find new way to synthesize drug molecules, and forcing drug developers to shore up their patent strategies.
The post Will AI Help Challenge Drug Patents, or Strengthen Them? appeared first on DrugPatentWa…


New patent expiration for Astrazeneca Pharms drug EPANOVA

Annual Drug Patent Expirations for EPANOVA Epanova is a drug marketed by Astrazeneca Pharms and is included in one NDA. There are nine patents protecting this drug. This drug has…
The post New patent expiration for Astrazeneca Pharms drug EPANOVA appea…


Do NOT follow this link or you will be banned from the site!